Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

December 31, 2019

Conditions
Active TuberculosisTuberculosis, ExtrapulmonaryTuberculosis, Pulmonary
Interventions
DIAGNOSTIC_TEST

Nanodisk-MS assay

Nanodisk-MS assay is a recently reported novel assay for quantitative detection of various MTB antigen peptides, using nanotechnology and mass spectrometry that showed remarkable sensitivity and specificity in diagnosing active pulmonary and extrapulmonary TB. This assay detected MTB-specific antigens, CFP-10 and ESAT-6, in patients' serum samples.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
collaborator

Prince of Wales Hospital, Shatin, Hong Kong

OTHER

collaborator

Alice Ho Miu Ling Nethersole Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT03271567 - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients | Biotech Hunter | Biotech Hunter